PNPLA3 and metabolic dysfunction-associated steatotic liver disease: These findings provide new evidence for the regulatory mechanisms of PNPLA3-I148M on lipid metabolism, mitochondrial dysfunction, and liver fibrosis, which will help to improve the understanding of the biological functions of PNPLA3 mutants and facilitate the development of therapeutic strategies for patients with NAFLD carrying the I148M allele.